Cargando…
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials
An efficacious COVID-19 vaccine is currently the world's leading research priority. Several nations have indicated that if there is a compelling case for use of a vaccine before it is licensed, they would be prepared to authorise its emergency use or conditional approval on public health ground...
Autores principales: | Singh, Jerome Amir, Upshur, Ross E G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832518/ https://www.ncbi.nlm.nih.gov/pubmed/33306980 http://dx.doi.org/10.1016/S1473-3099(20)30923-3 |
Ejemplares similares
-
Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities
por: Dal-Ré, Rafael, et al.
Publicado: (2021) -
COVID-19 vaccination for people with severe mental illness: why, what, and how?
por: Mazereel, Victor, et al.
Publicado: (2021) -
Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
por: Dockrell, Hazel M., et al.
Publicado: (2022) -
Beneficial non-specific effects of live vaccines against COVID-19 and other unrelated infections
por: Aaby, Peter, et al.
Publicado: (2023) -
Catecholamine physiology and its implications in patients with COVID-19
por: Gubbi, Sriram, et al.
Publicado: (2020)